There were 952 press releases posted in the last 24 hours and 357,908 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Gilenya (fingolimod): Drug Safety Communication - Severe Worsening of Multiple Sclerosis After Stopping the Medicine

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image